Relay Therapeutics, Inc. Rings the Opening Bell in Celebration of its IPO

ABOUT THIS EVENT

Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled insights into protein motion, rang the Nasdaq Opening Bell remotely from across the country.

In celebration of its IPO, Sanjiv K. Patel, M.A, M.D., MBA, President & CEO, rang the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.